We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

New Method of Noninvasive Blood-Flow Analysis for Heart Failure Marks Breakthrough in Vital Monitoring

By HospiMedica International staff writers
Posted on 05 Jun 2023
Print article
Image: The NIVA venous waveform technology represents a major innovation in vital monitoring (Photo courtesy of VoluMetrix)
Image: The NIVA venous waveform technology represents a major innovation in vital monitoring (Photo courtesy of VoluMetrix)

Heart failure is a global health issue, affecting millions and is one of the primary causes for elderly patient hospitalizations. Complications often arise in patients with heart failure due to the development of congestion, or fluid overload within the vascular system. This fluid imbalance exacerbates symptoms, leads to increased hospitalization rates, and is associated with higher readmission figures. Existing limitations in heart failure monitoring render it difficult for healthcare providers to effectively and precisely measure congestion levels, whether at home, in a clinic, or in a hospital setting. Most patients are tracked through clinical symptoms and weights, but these indicators prove unreliable and tend to manifest late in the disease progression. Although monitoring cardiac filling pressures is considered the gold standard in heart failure management, it requires invasive procedures or the implantation of devices. Hemodynamic monitoring is often not employed for most patients due to the absence of affordable, accurate, portable, and non-invasive monitoring solutions. But that could now change with the development of a wrist-worn device capable of providing non-invasive, real-time estimates of cardiac filling pressure across various care settings.

VoluMetrix (Nashville, TN, USA) has pioneered the NIVAHF, a device specifically designed for non-invasive volume status monitoring in heart failure patients. The company's innovative Non-Invasive Venous Waveform Analysis (NIVA) technology, a proprietary venous waveform system, presents a significant breakthrough in the field of vital monitoring technology. The venous waveform is a heart- and respiratory-activity-generated energy-based signal that reflects various physiological conditions, including pulse rate, respiration, and intravascular and extravascular dynamics.

VoluMetrix is evolving NIVA technology to enhance hemodynamic assessment via three major steps: signal capture with a non-invasive wrist sensor, signal deconstruction to map individual waveform amplitudes within a patient, and signal decoding. The NIVAHF device from VoluMetrix has been granted the U.S. Food and Drug Administration's (FDA) Breakthrough Device designation. Additionally, a USD 3 million NIH SBIR Phase IIb grant has been awarded to VoluMetrix to support the development and validation of NIVAHF, thus facilitating the device's availability to patients and healthcare providers.

Related Links:

Platinum Supplier
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Supplier
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Gold Supplier
POC Blood Gas Analyzer
Stat Profile Prime Plus
Polyp Retrieval Trap
Polyp Trap

Print article


Surgical Techniques

view channel
Image: The ARC-IM Stimulator with brain-computer interface restores arm, hand, and finger function after spinal cord injury (Photo courtesy of ONWARD Medical)

First-in-Human Implant of Thought-Driven Movement Device to Treat Spinal Cord Injury

In order to walk, signals from the brain are sent to neurons in the lumbosacral part of the spinal cord. When a spinal cord injury occurs, it cuts off this essential communication between the brain and... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The broad-spectrum POC coagulometer is well-suited for emergency room and emergency vehicle use (Photo courtesy of Perosphere)

Novel POC Coagulometer with Lab-Like Precision to Revolutionize Coagulation Testing

In emergency settings, when patients arrive with a bleed or require urgent surgery, doctors rely solely on clinical judgment to determine if a patient is adequately anticoagulated for reversal treatment.... Read more


view channel
Image: The global surgical lights market is expected to grow by close to USD 0.50 billion from 2022 to 2027 (Photo courtesy of Freepik)

Global Surgical Lights Market Driven by Increasing Number of Procedures

The global surgical lights market is set to witness high growth, largely due to the increasing incidence of chronic illnesses, a surge in demand for cosmetic and plastic surgeries, and untapped opportunities... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.